Kohli, M.; Joshi, K.; Beck, E.; Hagiwara, Y.; Van de Velde, N.; Igarashi, A.
Reply to Volkman et al. Comment on “Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434”. Vaccines 2024, 12, 1175.
https://doi.org/10.3390/vaccines12101175
AMA Style
Kohli M, Joshi K, Beck E, Hagiwara Y, Van de Velde N, Igarashi A.
Reply to Volkman et al. Comment on “Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434”. Vaccines. 2024; 12(10):1175.
https://doi.org/10.3390/vaccines12101175
Chicago/Turabian Style
Kohli, Michele, Keya Joshi, Ekkehard Beck, Yuriko Hagiwara, Nicolas Van de Velde, and Ataru Igarashi.
2024. "Reply to Volkman et al. Comment on “Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434”" Vaccines 12, no. 10: 1175.
https://doi.org/10.3390/vaccines12101175
APA Style
Kohli, M., Joshi, K., Beck, E., Hagiwara, Y., Van de Velde, N., & Igarashi, A.
(2024). Reply to Volkman et al. Comment on “Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434”. Vaccines, 12(10), 1175.
https://doi.org/10.3390/vaccines12101175
